Plastic solutions in healthcare are vital. However, the associated carbon emissions and wastefulness inherent in today’s linear economy in the healthcare sector needs to change. In order to manage the changes in a safe way, a strong value-chain collaboration is needed.

Key talking points include:
 

• Borealis BornewablesTM and BorcycleTM C solutions in existing polypropylene medical grades BormedTM case studies in the use of recycled and renewable feedstock, requiring no change in regulatory status.

• SÜDPACK PharmaGuardTM as a great mono- PP blister solution that can help the pharma industry to achieve a significant reduction in carbon emissions in a safe and efficient way.

Speakers: 

Jürgen Bodenmüller, Director of Business Development, SUDPACK Medica
Paulo Cavacas, Business Development Manager Healthcare, Borealis

With a science-based target set for 2030, Merck has launched a Supplier Decarbonization Program to lower the greenhouse gas emissions along its supply chain. Creating transparency of the emissions associated with the products Merck purchases is key to understanding how this reduction is progressing. Companies can demonstrate reductions of this typically large share of their emissions profile by collecting product carbon footprints (PCF) from their suppliers.

Whereas many companies have begun to assess their GHG emissions, few are at the stage of routinely calculating PCFs according to standardized methodologies. The PCF Guideline developed by Together for Sustainability addresses this challenge for molecules used in the chemical, pharmaceutical and other industries and provides tailored instructions on how to perform these calculations in compliance with existing guidelines like ISO or GHG protocol. This collaborative Information Classification: General publication moves corporations towards exchanging harmonized and reliable data that support tangible GHG emission reductions.

Speaker: Mathias Lemke, Senior Director and Head of Sourcing Raw Packaging Material, Merck Darmstadt

Ferrer's objective is to lead the change towards a more sustainable production by adopting criteria and commitments that allow minimizing the environmental footprint of its containers and packaging, being aware of its associated environmental problems, as well as the long periods of implementation of changes in the sector. 

For this, it has designed its Sustainable Packaging Model, with the participation of Anthesis Lavola. It is the result of methodological, objective and reproducible work, created to be integrated into the existing production model. 
 

To obtain the model, an analysis of the environmental footprint of the portfolio of its containers and packaging was based on the Life Cycle Analysis methodology. As a result, the Sustainable Packaging Model was created, setting objectives for 2030. The Model has 4 strategic axes and each one has specific and monitorable objectives to achieve them:
 

1) Design for Good

2) Natural resources protection

3) Zero Waste loop

4) Collaboration
 

It is an initiative that can serve as an example and inspiration to other sectors and companies of the event that want to start their path towards the circularity of packaging.
 

Speakers:

Berta Mota, Head of Circular Economy, Anthesis Lavola

Victor Cañada, Sustainability Advisor, Ferrer

The complexity and risks found within the global pharma supply chain cannot be understated and key stakeholders from customers to regulators, and investors are increasingly expecting the industry to both manage ESG risks and embed sustainability throughout the value chain.

This can only be achieved through industry-wide collaboration that establishes shared frameworks for what a responsible supply chain looks like. The Pharmaceutical Supply Chain Initiative (PSCI) and our membership of 70+ pharma and healthcare companies are leading this collaboration.

Through our Shared Audit Program, we are putting ESG into practice and building responsible supply chains.

Speaker: Enric Bosch Rado, Global Third party manager Chemicals Manager / Human Pharma supply chain, Boehringer Ingelheim

Join the discussion with our thought leaders from across pharma to discuss what’s next for the sector in terms of sustainability and the logistics of creating a circular economy.

• Building a circular economy through collaboration

• Setting targets and defining your sustainability strategy

• Sharing current practices in packaging, process chemicals and manufacturing to improve other sectors

Moderator:
Jürgen Bodenmüller, Director of Business Development, SUDPACK Medica

Panellists:

Berta Mota, Head of Circular Economy, Anthesis Group

Enric Bosch Rado, Global Third party manager Chemicals Manager / Human Pharma supply chain, Boehinger Ingelheim
Paulo Cavacas, Business Development Manager Healthcare, Borealis